SonoTek Corporation Holds Q4 2026 Earnings Call Focus on Growth Outlook SYM Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines Chinas Innovent Biologics and Pfizer Forge Potential 105 Billion Drug Collaboration